Francesco Passamonti

1999–2025 年に発表

181
論文数
34,252
被引用数
90
h 指数
171
i10 指数

被引用数

Francesco Passamonti の年別被引用数2001 年: 被引用 5 件2002 年: 被引用 3 件2003 年: 被引用 5 件2004 年: 被引用 5 件2005 年: 被引用 56 件2006 年: 被引用 97 件2007 年: 被引用 122 件2008 年: 被引用 142 件2009 年: 被引用 144 件2010 年: 被引用 152 件2011 年: 被引用 197 件2012 年: 被引用 257 件2013 年: 被引用 271 件2014 年: 被引用 259 件2015 年: 被引用 305 件2016 年: 被引用 242 件2017 年: 被引用 209 件2018 年: 被引用 214 件2019 年: 被引用 680 件2020 年: 被引用 1,044 件2021 年: 被引用 926 件2022 年: 被引用 920 件2023 年: 被引用 793 件2024 年: 被引用 1,461 件2025 年: 被引用 503 件2026 年: 被引用 7 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,939 件、この内訳の 22.9%イタリア: 引用元論文 904 件、この内訳の 10.7%ドイツ: 引用元論文 652 件、この内訳の 7.7%イギリス: 引用元論文 607 件、この内訳の 7.2%フランス: 引用元論文 559 件、この内訳の 6.6%スペイン: 引用元論文 399 件、この内訳の 4.7%中国: 引用元論文 250 件、この内訳の 3%カナダ: 引用元論文 247 件、この内訳の 2.9%スイス: 引用元論文 237 件、この内訳の 2.8%オランダ: 引用元論文 212 件、この内訳の 2.5%オーストリア: 引用元論文 190 件、この内訳の 2.2%スウェーデン: 引用元論文 183 件、この内訳の 2.2%
0%22.9%その他 24.6%

分野

  • Medicine90.3%
  • Biochemistry, Genetics and Molecular Biology5.9%
  • Immunology and Microbiology2.6%
  • Computer Science0.3%
  • Chemistry0.2%
  • Psychology0.1%
  • その他0.6%

トピック

  • Myeloproliferative Neoplasms: Diagnosis and Treatment18.2%
  • Acute Myeloid Leukemia Research13.2%
  • Chronic Myeloid Leukemia Treatments6.1%
  • Kruppel-like factors research5.9%
  • Eosinophilic Disorders and Syndromes5.6%
  • Cytokine Signaling Pathways and Interactions2.5%
  • その他48.5%

共著者

全論文

検索で開く
  1. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Richard A. Larson, Michelle M. Le Beau, Mignon L. Loh, Bob Löwenberg, Elizabeth Macintyre, Luca Malcovati, Charles G. Mullighan, Charlotte M. Niemeyer, Olatoyosi Odenike, Seishi Ogawa, Alberto Órfão, Elli Papaemmanuil, Francesco Passamonti, Kimmo Porkka, Ching‐Hon Pui, Jerald P. Radich, Andreas Reiter, Marı́a Rozman, Martina Rudelius, Michael R. Savona, Charles A. Schiffer, Annette Schmitt‐Graeff, Akiko Shimamura, Jorge Sierra, Wendy Stock, Richard M. Stone, Martin S. Tallman, Jürgen Thiele, Hwei‐Fang Tien, Alexandar Tzankov, Alessandro M. Vannucchi, Paresh Vyas, Andrew H. Wei, Olga K. Weinberg, Agnieszka Wierzbowska, Mario Cazzola, Hartmut Döhner, Ayalew Tefferi - Blood 2022 被引用: 2,693

  2. A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders

    著者: , , , , , , , , - New England Journal of Medicine 2005 被引用: 3,459

  3. Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anna Angona, Rosa Ayala, Soo‐Mee Bang, Bruce Bank, Fiorenza Barraco, Eloise Beggiato, Fleur Samantha Benghiat, Massimiliano Bonifacio, Claire Bories, Gabriela Borsaru, Mette Brabrand, Andrei Braester, Andes Broliden, Veronika Buxhofer‐Ausch, Nathalie Cambier, Marianna Caramella, Benjamin Carpentier, Nicola Cascavilla, Maria Giraldo Castellano, Hung Chang, Chih‐Cheng Chen, June‐Won Cheong, Yunsuk Choi, Philip Choi, Maria Teresa Corsetti, Isabel Montero Cuadrado, Julia Cunningham, Gandhi Damaj, Valerio De Stefano, Robert Delage, Regina Garcĺa Delgado, José Miguel Torregrosa Diaz, Péter Dombi, Viviane Dubruille, Miklós Egyed, Daniel El Fassi, Anna Elinder-Camburn, Elena Maria Elli, Martin Ellis, Carmen Fava, Salman Fazal, Angela Fleischman, Lynda Foltz, María Laura Fox, Nashat Gabrail, Jose Valentĺn Garcĺa-Gutiérrez, Aaron T. Gerds, Stéphane Girault, Heinz Gisslinger, Alexandru Gluvacov, Yeow Tee Goh, Joachim R. Göthert, Nikki Granacher, Sebastian Grosicki, Vikas Gupta, Evgeni Hadjiev, Kaoutar Hafraoui, Aryan Hamed, Claire Harrison, Hans Carl Hasselbalch, Hanns Hauser, Mark Heaney, Holger Hebart, Jesús María Hernández‐Rivas, Victor Higuero Saavedra, Christopher Hillis, Hsin‐An Hou, Jonathan P. How, Daniel Huang, Marek Hus ほか 95 名 - The Lancet 2023 被引用: 185

  4. MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis

    著者: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2017 被引用: 532

  5. Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis

    著者: , , , , , , , , , , , , , , , , , , - JAMA Oncology 2015 被引用: 472

  6. A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)

    著者: , , , , , , , , , , , , , - Blood 2009 被引用: 968

  7. DIPSS Plus: A Refined Dynamic International Prognostic Scoring System for Primary Myelofibrosis That Incorporates Prognostic Information From Karyotype, Platelet Count, and Transfusion Status

    著者: , , , , , , , , , , , , - Journal of Clinical Oncology 2010 被引用: 1,032

  8. Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera

    著者: , , , , , , , , , , , , , , , , - New England Journal of Medicine 2015 被引用: 872

  9. Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet

    著者: , , , , , , , , , , , , , , , , , , , , , , - Leukemia 2018 被引用: 552

  10. Momelotinib versus best available therapy in patients with myelofibrosis previously treated with ruxolitinib (SIMPLIFY 2): a randomised, open-label, phase 3 trial

    著者: , , , , , , , , , , , , - The Lancet Haematology 2017 被引用: 315

  11. New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment

    著者: , , , , , , , , , , , - Blood 2008 被引用: 1,237

  12. Revised response criteria for myelofibrosis: International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) and European LeukemiaNet (ELN) consensus report

    著者: , , , , , , , , , , , , , , , - Blood 2013 被引用: 379

  13. Janus kinase-2 inhibitor fedratinib in patients with myelofibrosis previously treated with ruxolitinib (JAKARTA-2): a single-arm, open-label, non-randomised, phase 2, multicentre study

    著者: , , , , , , , , , , , , , , , - The Lancet Haematology 2017 被引用: 330

  14. Development and validation of an International Prognostic Score of thrombosis in World Health Organization–essential thrombocythemia (IPSET-thrombosis)

    著者: , , , , , , , , , , , , , , , , - Blood 2012 被引用: 589

  15. A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Leukemia 2017 被引用: 334

  16. A prognostic model to predict survival after 6 months of ruxolitinib in patients with myelofibrosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Blood Advances 2022 被引用: 116

  17. Indication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis: updated recommendations by the EBMT/ELN International Working Group

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Haematology 2023 被引用: 96

  18. Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Francisco Cervantes, Peter Johansson, Tiziano Barbui, Giovanni Barosi, Alessandro M. Vannucchi, Francesco Passamonti, Björn Andréasson, Maria L Ferarri, Alessandro Rambaldi, Jan Samuelsson, Gunnar Birgegård, Ayalew Tefferi, Ruben A. Mesa - Journal of Clinical Oncology 2012 被引用: 458

  19. Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Leukemia 2013 被引用: 677

  20. MANIFEST: Pelabresib in Combination With Ruxolitinib for Janus Kinase Inhibitor Treatment-Naïve Myelofibrosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2023 被引用: 85

  21. Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Francesco Passamonti, Fabio Ciceri, Niccolò Bolli, Alessandro Rambaldi, Wolfgang Kern, Shahram Kordasti, Françesc Solé, Laura Palomo, Guillermo Sanz, Armando Santoro, Uwe Platzbecker, Pierre Fenaux, Luciano Milanesi, Torsten Haferlach, Gastone Castellani, Matteo Giovanni Della Porta - Journal of Clinical Oncology 2021 被引用: 225

  22. Myelofibrosis

    著者: , - Blood 2022 被引用: 132

  23. Appropriate management of polycythaemia vera with cytoreductive drug therapy: European LeukemiaNet 2021 recommendations

    著者: , , , , , , , , , , , , , , , - The Lancet Haematology 2022 被引用: 113

  24. COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nicola Fracchiolla, Austin Kulasekararaj, Toni Valković, Christian Bjørn Poulsen, Marina Machado, Andreas Glenthøj, И. О. Стома, Zdeněk Ráčil, Klára Piukovics, Milan Navrátil, Ziad Emarah, Uluhan Sili, Johan Maertens, Ola Blennow, Rui Bergantim, Carolina García‐Vidal, Lucia Prezioso, Anna Guidetti, Maria Ilaria Del Principe, Marina Popova, Nick de Jonge, Irati Ormazabal‐Vélez, Noemí Fernández, Iker Falces‐Romero, Annarosa Cuccaro, Stef Meers, Caterina Buquicchio, Darko Antić, Murtadha Al‐Khabori, Ramón García‐Sánz, Monika Biernat, Maria Chiara Tisi, Ertan Sal, Laman Rahimli, Nataša Čolović, Martin Schönlein, María Calbacho, Carlo Tascini, Carolina Miranda, Nina Khanna, Gustavo‐Adolfo Méndez, Verena Petzer, Jan Novák, Caroline Besson, Rémy Duléry, Sylvain Lamure, Márcio Nucci, Giovanni Paolo Maria Zambrotta, Павел Зак, Güldane Cengiz Seval, Valentina Bonuomo, Jiřı́ Mayer, Alberto López‐García, Maria Vittoria Sacchi, Stephen Booth, Fabio Ciceri, Margherita Oberti, Marco Salvini, Macarena Izuzquiza, Raquel Nunes Rodrigues, Emanuele Ammatuna, Aleš Obr, Raoul Herbrecht, Lucía Núñez-Martín-Buitrago, Valentina Mancini, Hawraa Shwaylia, Mariarita Sciumé, Jenna Essame, Marietta Nygaard, Josip Batinić ほか 96 名 - Journal of Hematology & Oncology 2021 被引用: 318